Transaction in Own Shares

Summary by AI BETAClose X

Fevertree Drinks plc has announced the purchase of 181,556 ordinary shares between August 3rd and August 7th, 2026, with an aggregated volume-weighted average price of approximately 857.75 pence per share, ranging from 839.00 pence to 890.00 pence. The company intends to cancel these repurchased shares, which were acquired under the authority granted by shareholders at the 2025 Annual General Meeting.

Disclaimer*

Fevertree Drinks PLC
11 August 2026
 

11th August 2026                   

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 3rd August to 7th August 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

03 August 2026

XLON

851.8083

30,602

840.5000

868.0000

03 August 2026

AIMX

845.0000

20,000

845.0000

845.0000

04 August 2026

XLON

849.4386

23,020

839.0000

857.5000

05 August 2026

XLON

854.2354

26,186

850.5000

859.0000

05 August 2026

AIMX

856.5000

10,000

856.5000

856.5000

06 August 2026

XLON

872.8729

41,700

856.5000

882.0000

07 August 2026

XLON

884.1041

40,448

873.5000

890.0000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/9568P_1-2026-8-10.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings